{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T10:10:33Z","timestamp":1760695833136,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.meddos.2023.02.003","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T07:45:02Z","timestamp":1679903102000},"page":"140-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Feasibility-guided automated planning for stereotactic treatments of prostate cancer"],"prefix":"10.1016","volume":"48","author":[{"given":"Carmela","family":"Romano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Viola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Craus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0678-4996","authenticated-orcid":false,"given":"Milena","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bonome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pierro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milly","family":"Buwenge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Arcelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-3410","authenticated-orcid":false,"given":"Alessio Giuseppe","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1276-5070","authenticated-orcid":false,"given":"Francesco","family":"Deodato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6711-350X","authenticated-orcid":false,"given":"Savino","family":"Cilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.meddos.2023.02.003_bib0001","doi-asserted-by":"crossref","first-page":"963e974","DOI":"10.3109\/0284186X.2012.719635","article-title":"Prostate alpha\/beta revisited e an analysis of clinical results from 14168 patients","volume":"51","author":"Dasu","year":"2012","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.meddos.2023.02.003_bib0002","first-page":"e17ee24","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: \u03b1\/\u03b2 =1.4 (0.9-2.2) Gy","volume":"82","author":"Miralbell","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2023.02.003_bib0003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1756-9966-28-117","article-title":"Modeling of alpha\/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer","volume":"28","author":"Marzi","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.meddos.2023.02.003_bib0004","doi-asserted-by":"crossref","first-page":"600e605","DOI":"10.1016\/j.ijrobp.2010.11.080","article-title":"Estimation of alpha\/beta for late rectal toxicity based on RTOG 94-06","volume":"81","author":"Tucker","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.meddos.2023.02.003_bib0005","doi-asserted-by":"crossref","first-page":"216e229","DOI":"10.1016\/j.clon.2014.01.008","article-title":"Is biochemical relapse-free survival after profoundly hypofractionated radiotherapy consistent with current radiobiological models?","volume":"26","author":"Tree","year":"2014","journal-title":"Clin Oncol"},{"key":"10.1016\/j.meddos.2023.02.003_bib0006","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic Body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2023.02.003_bib0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.meddos.2023.02.003_bib0008","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.meddos.2023.02.003_bib0009","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"PACE Trial Investigators. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.meddos.2023.02.003_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2020.04.037","article-title":"Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: a systematic review and meta-analysis of phase III randomized trials","volume":"148","author":"Lehrer","year":"2020","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.meddos.2023.02.003_bib0011","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejmp.2016.03.011","article-title":"SBRT for prostate cancer: challenges and features from a physicist prospective","volume":"32","author":"Mancosu","year":"2016","journal-title":"Phys Med"},{"issue":"4","key":"10.1016\/j.meddos.2023.02.003_bib0012","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.prro.2011.11.012","article-title":"Variation in external beam treatment plan quality: an inter-institutional study of planners and planning systems","volume":"2","author":"Nelms","year":"2012","journal-title":"Pract Radiat Oncol"},{"issue":"7","key":"10.1016\/j.meddos.2023.02.003_bib0013","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00066-015-0822-6","article-title":"A feasibility dosimetric study on prostate cancer: are we ready for a multicenter clinical trial on SBRT?","volume":"191","author":"Marino","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.meddos.2023.02.003_bib0014","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmp.2019.05.003","article-title":"Plan quality improvement by DVH sharing and planner's experience: results of a SBRT multicentric planning study on prostate","volume":"62","author":"Villaggi","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.meddos.2023.02.003_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.824532","article-title":"Personalized automation of treatment planning for linac-based stereotactic body radiotherapy of spine cancer","volume":"12","author":"Cilla","year":"2022","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.meddos.2023.02.003_bib0016","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.prro.2017.02.007","article-title":"An analysis of knowledge-based planning for stereotactic body radiation therapy of the spine","volume":"7","author":"Joy","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"10.1016\/j.meddos.2023.02.003_bib0017","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/acm2.12872","article-title":"Automated planning through robust templates and multicriterial optimization for lung VMAT SBRT of lung lesions","volume":"21","author":"Marrazzo","year":"2020","journal-title":"J Appl Clin Med Phys"},{"issue":"3","key":"10.1016\/j.meddos.2023.02.003_bib0018","article-title":"Automated planning for prostate stereotactic body radiation therapy on the 1.5 T MR-Linac","volume":"7","author":"Naccarato","year":"2022","journal-title":"Adv Radiat Oncol"},{"issue":"9","key":"10.1016\/j.meddos.2023.02.003_bib0019","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/acm2.13345","article-title":"Automated treatment planning of prostate stereotactic body radiotherapy with focal boosting on a fast-rotating O-ring linac: plan quality comparison with C-arm linacs","volume":"22","author":"De Roover","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.meddos.2023.02.003_bib0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmp.2018.01.016","article-title":"Evaluation of a commercial automatic treatment planning system for liver stereotactic body radiation therapy treatments","volume":"46","author":"Gallio","year":"2018","journal-title":"Phys Med"},{"issue":"11","key":"10.1016\/j.meddos.2023.02.003_bib0021","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/acm2.13025","article-title":"Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer","volume":"21","author":"Cilla","year":"2020","journal-title":"J Appl Clin Med Phys"},{"issue":"10","key":"10.1016\/j.meddos.2023.02.003_bib0022","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1002\/mp.12500","article-title":"A method for a priori estimation of best feasible DVH for organs-at-risk: validation for head and neck VMAT planning","volume":"44","author":"Ahmed","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.meddos.2023.02.003_bib0023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejmp.2020.12.015","article-title":"Personalized automation of treatment planning in head-neck cancer: a step forward for quality in radiation therapy?","volume":"82","author":"Cilla","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.meddos.2023.02.003_bib0024","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1748-717X-8-171","article-title":"Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study","volume":"8","author":"Alongi","year":"2013","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.meddos.2023.02.003_bib0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0360-3016(96)00601-3","article-title":"A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate","volume":"37","author":"van't Riet","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2023.02.003_bib0026","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2012.08.008","article-title":"QA makes a clinical trial stronger: evidence-based medicine in radiation therapy","volume":"105","author":"Weber","year":"2012","journal-title":"Radioth Oncol"},{"issue":"2","key":"10.1016\/j.meddos.2023.02.003_bib0027","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2015.01.046","article-title":"Quantifying unnecessary normal tissue complication risks due the suboptimal planning: a secondary study on RTOG126","volume":"92","author":"Moore","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2023.02.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180270","article-title":"automation in intensity modulated radiotherapy treatment planning\u2014a review of recent innovations","volume":"91","author":"Hussein","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.meddos.2023.02.003_bib0029","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejmp.2019.11.023","article-title":"Novel knowledge-based treatment planning model for hypofractionated radiotherapy of prostate cancer patients","volume":"69","author":"Chatterjee","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.meddos.2023.02.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178034","article-title":"Intercenter validation of a knowledge based model for automated planning of volumetric modulated arc therapy for prostate cancer. the experience of the german rapidplan consortium","volume":"12","author":"Schubert","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.meddos.2023.02.003_bib0031","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejmp.2017.06.026","article-title":"Dosimetric comparison of rapidplan and manually optimized plans in volumetric modulated arc therapy for prostate cancer","volume":"44","author":"Kubo","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.meddos.2023.02.003_bib0032","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.radonc.2016.06.022","article-title":"Clinical validation and benchmarking of knowledge-based IMRT and VMAT treatment planning in pelvic anatomy","volume":"120","author":"Hussein","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.meddos.2023.02.003_bib0033","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.radonc.2018.06.023","article-title":"Fully automated, multi-criterial planning for volumetric modulated arc therapy\u2013an international multi-center validation for prostate cancer","volume":"128","author":"Heijmen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.meddos.2023.02.003_bib0034","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3389\/fonc.2020.00943","article-title":"Automated radiotherapy planning for patient-specific exploration of the trade-off between tumor dose coverage and predicted radiation-induced toxicity: a proof of principle study for prostate cancer","volume":"10","author":"Bijman","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.meddos.2023.02.003_bib0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41598-019-56966-y","article-title":"Template-based automation of treatment planning in advanced radiotherapy: a comprehensive dosimetric and clinical evaluation","volume":"10","author":"Cilla","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.meddos.2023.02.003_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.636529","article-title":"Personalized treatment planning automation in prostate cancer radiation oncology: a comprehensive dosimetric study","volume":"11","author":"Cilla","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.meddos.2023.02.003_bib0037","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijrobp.2014.10.049","article-title":"Continuous monitoring and intrafraction target position correction during treatment improves target coverage for patients undergoing SBRT prostate therapy","volume":"91","author":"Lovelock","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2023.02.003_bib0038","doi-asserted-by":"crossref","first-page":"21704","DOI":"10.1118\/1.4860663","article-title":"Offline multiple adaptive planning strategy for concurrent irradiation of the prostate and pelvic lymph nodes","volume":"41","author":"Qi","year":"2014","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.meddos.2023.02.003_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213002","article-title":"Real-time adaptive planning method for radiotherapy treatment delivery for prostate cancer patients, based on a library of plans accounting for possible anatomy configuration changes","volume":"14","author":"Antico","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.meddos.2023.02.003_bib0040","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.prro.2016.07.004","article-title":"Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.meddos.2023.02.003_bib0041","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.meddos.2022.02.003","article-title":"The dosimetric advantages of perirectal hydrogel spacer in men with localized prostate cancer undergoing stereotactic ablative radiotherapy (SABR)","volume":"47","author":"Sturt","year":"2022","journal-title":"Med Dos"}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394723000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394723000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:32:53Z","timestamp":1760693573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394723000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"alternative-id":["S0958394723000201"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2023.02.003","relation":{},"ISSN":["0958-3947"],"issn-type":[{"type":"print","value":"0958-3947"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility-guided automated planning for stereotactic treatments of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2023.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}